# The Effect of Proton Pump Inhibition on Palpitations

Study · id `cardio:ct-nct03273634` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03273634](<https://clinicaltrials.gov/study/NCT03273634>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03273634

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 150 participants.

## Technical summary

Registry record NCT03273634. Randomized; double masking; primary purpose treatment. Start 2017-05-20 (actual); primary completion 2018-05-01 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 150 participants (enrolled count; ClinicalTrials.gov record NCT03273634, source copy `cardio:ctgov-nct03273634-2018-08-08`, retrieved 2026-10-26)
- Started: 2017-05-20 (actual) (ClinicalTrials.gov record NCT03273634, source copy `cardio:ctgov-nct03273634-2018-08-08`, retrieved 2026-10-26)
- Primary completion: 2018-05-01 (actual) (ClinicalTrials.gov record NCT03273634, source copy `cardio:ctgov-nct03273634-2018-08-08`, retrieved 2026-10-26)
- Completion: 2018-06-01 (actual) (ClinicalTrials.gov record NCT03273634, source copy `cardio:ctgov-nct03273634-2018-08-08`, retrieved 2026-10-26)
- Countries: Jordan (ClinicalTrials.gov record NCT03273634, source copy `cardio:ctgov-nct03273634-2018-08-08`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03273634-2018-08-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Effect of Proton Pump Inhibition on Palpitations
- Condition: Arrhythmia
- Intervention (Drug): Lansoprazole Pill
- Intervention (Drug): Placebo
- Lead sponsor: Jordan Collaborating Cardiology Group
- Lead sponsor class: OTHER
- Collaborator: University of Jordan
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry lists this organization as the lead sponsor: Jordan Collaborating Cardiology Group (`cardio:org-jordan-collaborating-cardiology-group`)

## Provenance

Content hash: 90b914ff703d831c0e4461e84265928496f3f3d5ab6d72cf377339564b9fca79
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
